NEW YORK (GenomeWeb News) – Indian biotech services company Jubilant Biosys has entered a co-marketing agreement with DiscoveRx to screen potential drug compounds, Jubilant said yesterday.

The agreement will enable Jubilant’s pharmaceutical customers to use DiscoveRx services such as the PathHunter and CampHunter cell lines and chemiluminescent detection technology.

The agreement will also allow DiscoveRx to offer screening solutions from India, Jubilant said.

Jubilant Biosys, based in Noida with facilities in Bangalore, is a subsidiary of Jubilant Organsys.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.